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THE SPECIFICITY OF THE KVEIM REACTION*
CARL T. NELSON, Mi). AN) BENJAMIN SCHWIMMER, M.D.
Kveim (1), in 1941, described a delayed cutaneous reaction in patients with
sarcoidosis following the intracutaneous injection of heated saline suspensions of
sareoid tissue. This reaction consisted of the formation of an indolent papule
which was notable for its slow evolution and its persistence. Biopsy of this
papule revealed histologically a sarcoid-like structure. No papule developed in
control subjects, including those with syphilis or lupus vulgaris.
Since this initial report, a number of investigators have studied the diagnostic
value and specificity of the Kveim reaction. Although the results of these studies
have not been in complete agreement, and have been subject to various interpre-
tations, most investigators have found that the specificity of the Kveim reaction
is high and that positive tests in diseases other than sarcoidosis are not common
(2—6). Characteristic Kveim responses, using suspensions of sarcoid tissue, have
occasionally been observed in some forms of tuberculosis, erythema nodosum,
idiopathic pulmonary fibrosis, and, with some antigens, even in normal persons
(2, 5—8). Until recently, however, the reported frequency of these reactions has
not been great, and positive cutaneous responses with suspensions of sarcoid
tissue prepared according to the method of Kveim, seem to have been limited for
the most part to patients with sarcoidosis. Thus, false-positive Kveim tests were
generally believed to be uncommon and those that were observed merely seemed
to reaffirm the truism that no biological test can he expected to be completely
specific at all times. Recently, however, data have been presented purporting to
show that the Kveim reaction is essentially without diagnostic specificity and
that it is of no value in the differentiation of tuberculosis from sarcoidosis (9, 10).
These findings seem to cast serious doubt on the reliability of the Kvcim test
and suggest that further critical studies of the specificity of the reaction are
warranted.
The purpose of this report is to summarize our results \vith the Kveim test in
335 individuals during the past seven years, using a single lot of Kveim suspen-
sion of established reactivity and specificity.
MATEnIAL5 AND METHODS
A single Kveim suspension prepared from microscopically-proved sarcoid
spleen tissue was used throughout the course of this study. The tissue was ground
and homogenized under sterile precautions in a mecharncal blender with 10
volumes of isotonic sodium chloride solution. No sand or other abrasive material
was used in the grinding process. The resulting suspension was then processed
and tested for sterility inn the manner previously described (3, 4).
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When injected intracutaneously, this antigen produced characteristic papular
Kveim responses in 11 of 12 patients with biopsy-confirmed and clinically active
sarcoidosis. It caused no similar response in 12 normal individuals and 24 patients
with diseases other than sarcoidosis. Seitz filtrates of this suspension produced no
papular reactions in any of the foregoing persons. This antigen, therefore, was
judged to be active and specific and suitable for clinical use.
For testing, 0.15 cc. of the suspension was injected intracutaneously as super-
ficially as possible into the flexor surface of the forearm, using a 22 gauge needle.
This is the method originally used by Kveim, and it requires no modifications.
The site of the injection was recorded for subsequent identification by measuring
its distance from the distal wrist fold.
Criteria for a positive Kveim test
For the purpose of this study, the Kveim test was regarded as positive if a
papule of any size developed at the injection site after a period of six to eight
weeks and if, upon excision of the reaction papule at the test site, a tuberculoid
reaction resembling sarcoidosis was found histologically. Test sites which
yielded non-specific granulomatous reactions or banal inflammatory changes on
histologic examination were recorded as negative. If no reaction papule was seen
or felt at the site of injection, the test was also read as negative. Biopsy of
macroscopically non-reactive test areas, advocated by some (5), was not at-
tempted since we feel that an intracutaneous test which is significant clinically
should at least be seen or felt when positive. To perform a biopsy on a papule
that isn't there, i.e. one that cannot be observed macroscopically, appears to us
to be an unjustified extension of the Kveim testing technic, and one that may
well serve as a source of confusion.
Standardization of Kveim antigen
In view of the crude nature of the suspension used in the Kveim test, standard-
ization of the specificity and reactivity of the antigen is not easy. Each lot of
Kveim suspension, therefore, must be tested for reactivity and specificity in
normal individuals, in patients with active sarcoidosis, and in patients with
diseases other than sarcoidosis before the material can be used for diagnostic
purposes. Moreover, these tests for reactivity and specificity must be repeated
at intervals during the shelf life of the antigen. Some suspensions prepared from
histologically typical sarcoid tissue may be totally inert when tested. Other
antigens prepared from comparable tissue sources by the same technic have been
found to be quite non-specific in that they yield papular reactions in virtually all
volunteers in whom the material is injected and tend to cause irritative tissue
responses which interfere with the gross and microscopic reading of the test.
Other antigenic preparations have proved to be satisfactory for a time, only to
lose either their specificity or reactivity as time went on. Some antigens remain
active and specific for years; others deteriorate and must be discarded. During the
past ten years, we have prepared 18 lots of Kveim antigen from the tissues of 15
patients with histologically-proved sarcoidosis. The fate of ten of these antigens
is summarized in Table I. These data serve to emphasize the difficulty in stand-
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TABLE I
Useful life of 10 Kveijn antigens prepared from various sources
Antigen Source Comments
PJ-1 Lymph node Retained potency and specificity 9 months. Supply exhausted.
PJ-2 Lymph node Retained potency and specificity 7 months. Supply exhausted.
Hogve Skin Inert
Blair Lymph node Retained potency and specificity 6 months. Supply exhausted.
PG-i Spleen Retained potency and specificity 22 months, then lost spe-
cificity.
DM-1 Spleen Retained potency and specificity 7 years.
Morales Lymph node Lost potency after 9 months.
JC-1 Skin Non-specific
SA-l Spleen Inert
BR-i Spleen Inert
ardizing Kveim antigen, and the need for evaluating the specificity and re-
activity of each particular lot of antigen at frequent intervals if it is to be used
in a skin testing procedure of this type.
CLINICAL MATERIAL
The patients included in this study were classified into six categories as
follows: (1) Sarcoid, biopsy-confirmed; (2) Probable sarcoid; (3) Probably not
sarcoid; (4) Active tuberculosis, bacteriologically-proved; (5) Other diseases;
and (6) Normal controls.
Sarcoid, biopsy-confirmed. There were 72 patients in whom the diagnosis of
sarcoidosis had been confirmed by tissue biopsy. In 56 patients the disease was
thought to be in an active phase at the time of cutaneous testing. In 16, the dis-
ease was classified as inactive since no new lesions of the skin, mucous mem-
branes or bones had been found for a period of several months prior to the time
of testing, nor had there been any evidence of progression of ocular symptoms,
hilar adenopathy, parenchymal involvement of the lungs, or superficial glandular
enlargement.
Probable sarcoid. There were 29 patients with typical clinical, roentgenographic,
and laboratory findings of sarcoidosis in whom no cutaneous lesions or enlarged
peripheral lymph nodes, or other easily obtained tissues were available for
biopsy. From a clinical standpoint, no diagnosis other than sarcoidosis could be
considered appropriate, but because of the lack of histologic verification these
patients could only be considered as suspected cases of this disease.
Probably not sarcoid. This group consisted of 35 individuals who exhibited a
variety of clinical findings, one or more of which are sometimes associated with
sarcoidosis. In these patients subsequent observations often failed to establish a
diagnosis, but as time elapsed at least it became evident that sarcoidosis was not
a likelihood. In other cases, the Kveim test was performed merely because of a
single laboratory finding, without any real expectancy that the true diagnosis
would be sarcoidosis.
Active tuberculosis, bacteriologically-proved. There were 99 patients with active
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tuberculosis, confirmed by bacteriologic studies, who were available for testing.
Virtually all of these patients suffered from pulmonary tuberculosis, and in only
four were there manifestations of cutaneous or mucosal involvement.
Other diseases. This was a group of 82 patients known to have diseases other
than sarcoidosis or tuberculosis. These patients had a wide variety of ailments,
general and cutaneous, including malignant, degenerative, infectious, and met-
abolic diseases.
Normal controls. This group of 18 individuals was made up of physicians and
nurses who were active and in good health at the time of testing.
RESULTS
The results of the Kveim tests in the 335 patients included in this study are
summarized in Table II. The data in this table show that the Kveim reaction was
positive in 53, or 74 per cent, of the 72 patients in the biopsy-confirmed group.
It should be mentioned, however, that 16 patients were believed to be in an
inactive phase of the disease when tested. Of the 56 patients tested during the
active phase of the illness, all but three yielded positive tests. Twelve patients
whose intra-cutaneous test reactions were positive during the active stages of the
illness lost their reactivity to Kveim antigen when the disease process became
clinically inactive. These findings are in accord with previous observations (3—6)
and support the general impression that the Kveim response tends to lessen as
the disease process undergoes regression. As noted previously (3—5), the capacity
to produce a characteristic Kveim response does not seem to have any definite
relationship to the type or extent of clinical involvement, duration of the disease,
degree of sensitivity to tuberculin, age, sex, color, or to changes in the values for
certain blood constituents commonly observed in sarcoidosis. It may be said,
therefore, that positive Kveim reactions occur in a relatively high proportion of
patients with active sarcoidosis, and that the response tends to become negative
as the disease enters a stage of remission. Sometimes, however, patients who are
judged clinically to be in remission will continue to have a positive reaction,
while a few with obvious progressive disease may fail to react to the intra-
cutaneous test. It is of some interest that 4 patients in this series who originally
TABLE H
Resnits of the Kreim lest in p335 patients
Positive Kveim Tests
Diagnosis Paties
Number Per cent
1. Sarcoid, biopsy-confirmed 72 53 74
2. Probable sarcoid 29 17 59
3. Probably not sarcoid 35 1 3
4. Active tuberculosis, bacteriologically-proved. . . 99 1 1
5. Other diseases 82 0 0
6. Normal controls 18 0 0
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gave positive Kveim responses, became negative when the disease regressed
clinically, only to become Kveim-positive again 7 to 28 months later when there
was obvious clinical recrudescence of the sarcoidosis.
Of the 29 patients in the probable sarcoid group, 17, or 59 per cent, yielded
positive Kveim reactions. Twenty patients in this group were judged to have
clinically active disease at the time of testing but three of these failed to react to
the Kveim antigen.
Only one of the 35 patients included in the probably riot sarcoid group showed
a positive Kveim reaction. This patient had typical lesions of erythema nodosurn
at the time of testing and was later diagnosed as a ease of beryllosis.
Of the 99 patients with active tuberculosis, one, or approximately 1 per cent,
had a positive Kveim reaction. Histologically, the positive Kveim reaction in this
patient was open to some question in that two pathologists felt that the reaction
was inconclusive. Two other observers, however, believed the tissue response to be
sufficiently suggestive of sarcoid to he classified as a positive test. Six additional
patients with active tuberculosis developed small papules (l—3 mm. in diameter)
at the sites of intracutaneous Kveim tests. Since histologic examination of each
of these test sites showed non-specific inflammatory changes, the reactions were
regarded as negative.
Of the 82 patients with other diseases and 18 normal individuals included in
this series, none yielded positive Kveim reactions. In summary, then, of 234
persons who did not have sarcoidosis, two showed false positive Kveim reactions.
COMMENT
These studies indicate that the Kveim reaction is a highly specific test for
sarcoidosis and that it is infrequently positive in other diseases. Only two false-
positive reactions were observed among 234 patients who did not have sar-
coidosis, an incidence of less than 1 per cent. Other investigators have observed
an incidence of 3 to 6 per cent false-positive Kveim reactions, hut as Siltzbaeh
and Ehrlieh have pointed out (5), this may be considered to be a satisfactorily
low rate of false-positive reactions for a crude biologic test of this sort.
Since the reactivity to Kveim antigen is not known to he related to age, sex,
color, or type of clinical involvement, the inability of Sones, Israel and their
coworkers (9, 10) to confirm the specificity of the Kveirn reaction cannot logially
be explained on the basis of differences in the character of their clinical material.
Although these investigators adopted the habit of obtaining biopsies from
Kveim test sites even when no reaction papule could he observed clinically, the
number of false-positive reactions found by them in this way apparently was
likewise not sufficient to explain the discrepancy in their results. It seems more
likely that the failure of these investigators to corroborate the specificity of the
Kveim test was due to deficiencies in their antigenie preparations. The fact that
they obtained positive Kveim reactions in 8 to 42 per cent of patients known not
to have sarcoidosis is prima facie evidence that the antigenie preparations used
had lost their specificity and that they were no longer suitahle for clinical testing.
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SUMMARY
The Kveim test for sarcoidosis has been studied in 335 individuals, using a
single lot of antigen prepared from sarcoid spleen tissue. These studies indicate
that the Kveim test is specific for sarcoidosis and that it is rarely positive in other
diseases.
Among 234 persons who did not have sarcoidosis, only two false-positive
Kveim reactions were observed. Included therein were 99 patients with active
tuberculosis, only one of whom yielded a positive Kveim test.
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DISCUSSION
DR. ADOLPH ROSTENBERG, JE. (Chicago, Ill.): I think Dr. Nelson is to be
congratulated for his persistence in studying this reaction, which is potentially a
very important reaction as I feel sarcoidosis is a very common disease and if we
had a good epidemiologic tool we would have better evidence concerning its
prevalence.
The first point about the Kveim reaction is its specificity. If, as Dr. Nelson
thinks, it is specific, the results of the testing would corroborate the view of many
that sarcoidosis has nothing to do with tuberculosis per se. The next point about
the test I should like to discuss is, why the inordinate delay in the reaction? It
takes six to eight weeks to appear. This is very hard to understand and hard to
interpret. I can give you no explanation. It may be that sarcoidosis is not an
infectious disease at all, but that it is a reaction to some alien material. The
delay in the Kveim test might then be explained on the assumption that in the
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antigen there is some alien material to which the body ultimately reacts but
which requires sufficient time. It is interesting to note that Boeck's first case
died in about 1940 of a hypernephroma, which was approximately fifty years
after Boeck first studied him. Careful post-mortem study showed no evidence of
sarcoidosis; but the patient had given a positive Kveim test, even though there
was no clinical evidence of the disease.
DR. HERMAN BEERMAN (Philadelphia, Pa.): I wish I had the astuteness of
Dr. Rostenberg but I cannot admit that Dr. Nelson has solved the matter of
specificity of the Kveim reaction. Without going back to our work of last year,
we still find positive reactions among tuberculosis patients; and in a group of
Nelson's patients of sarcoidosis only about 74 per cent gave a positive reaction.
In a test that is so labile as to require repeated standardization of the antigen
and such laborious procedure as going through elaborate histologic technics, one
must look with some doubt on the practicality of the test as an easily used tool.
Therefore, I feel that while his work has elaborated the problem of making the
test useful, I do not believe that the procedure is as useful as the serologic tests
for syphilis, for instance.
DR. CARL T. NELSON (in closing): I certainly have no adequate explanation
for the delayed reactivity of the Kveim reaction in patients with sarcoidosis.
It is a very difficult phenomenon to explain. The Scandinavian workers have
postulated an allergic basis for the reaction, but the latent period would seem to
be inordinately long for that. We have done certain experiments with fractions of
the Kveim antigen and, in some individuals with high reactivity to the whole
antigen, we have occasionally seen a reasonably good Kveim response with lipid
extracts of the antigen. This is an inconstant finding, however. We think that
this represents reactivity to lipid or lipoprotein substances, but we have no
absolute proof of this.
The fact that Kveim reactivity can persist for a long time after the disease
is quiescent clinically is well known. It is also apparent from our series of cases
that the Kveim test not uncommonly turns negative as the sarcoidosis enters a
stage of clinical remission. In some cases, at least, there seems to be some rela-
tionship between Kveim reactivity and the clinical activity of the sarcoidosis.
Dr. Beerman's points are well taken. The chemical make-up of Kveim antigen
is not known and there is no easy way to standardize its reactivity. Therefore,
if one is to use Kveim antigen one must test it regularly in a sufficient number of
patients to be sure that non-specific reactions are not occurring, and that the
material has not lost its potency. If either occurs, the antigen must be discarded
and a new supply must be sought.
It is true that the diagnosis of sarcoidosis is only occasionally determined
by the results of the Kveim test. Most patients with sarcoidosis will have in-
volved tissue available for biopsy but, in those that do not, then the test may
be very useful. While the Kveim test may not have wide diagnostic application,
the hope is that if we can uncover the mechanism of this reaction we may some
day unravel the pathogenesis of sarcoidosis. In closing, I should like to thank
Dr. Rostenberg and Dr. Beerman for their remarks.
